Insider Transactions in Q4 2020 at Dicerna Pharmaceuticals Inc (DRNA)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2020
|
Adam Koppel Director |
SELL
Open market or private sale
|
Indirect |
1,000,000
-24.51%
|
$23,000,000
$23.4 P/Share
|
|
Dec 01
2020
|
James B Weissman Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct |
4,360
-12.04%
|
$109,000
$25.21 P/Share
|
|
Dec 01
2020
|
James B Weissman Chief Operating Officer & EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
4,360
+10.74%
|
$13,080
$3.42 P/Share
|
|
Dec 01
2020
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,185
-23.59%
|
$204,625
$25.19 P/Share
|
|
Dec 01
2020
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,185
+19.09%
|
$24,555
$3.42 P/Share
|
|
Nov 04
2020
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
30,000
-75.0%
|
$660,000
$22.75 P/Share
|
|
Nov 04
2020
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$360,000
$12.93 P/Share
|
|
Nov 02
2020
|
James B Weissman Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct |
4,360
-12.04%
|
$87,200
$20.95 P/Share
|
|
Nov 02
2020
|
James B Weissman Chief Operating Officer & EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
4,360
+10.74%
|
$13,080
$3.42 P/Share
|
|
Nov 02
2020
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,185
-23.59%
|
$171,885
$21.03 P/Share
|
|
Nov 02
2020
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,185
+19.09%
|
$24,555
$3.42 P/Share
|
|
Oct 20
2020
|
James B Weissman Chief Operating Officer & EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+23.89%
|
$20,000
$2.97 P/Share
|
|
Oct 16
2020
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
16,370
-38.17%
|
$343,770
$21.0 P/Share
|
|
Oct 16
2020
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
16,370
+27.63%
|
$49,110
$3.42 P/Share
|
|
Oct 15
2020
|
James B Weissman Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct |
8,720
-28.52%
|
$174,400
$20.2 P/Share
|
|
Oct 15
2020
|
James B Weissman Chief Operating Officer & EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
8,720
+22.19%
|
$26,160
$3.42 P/Share
|